Synapse Open Synapse
Biology

StockWatch: Amid Nvidia Turmoil, What Happens to Its Life Sciences Collaborations?

GEN · · 11 min read

While Nvidia doesn’t develop new therapies, instruments, or reagents, its AI technology powers numerous collaborations with biopharma and lab tools giants stretching back at least five years.

Latest from GEN